Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Amoroso

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Journal of Cancer Research and Clinical Oncology|July 7, 2012
First-line chemotherapy with planned sequential administration of cisplatin/gemcitabine followed by docetaxel in elderly 'unfrail' patients with advanced non-small-cell lung cancer: a multicenter phase II studyC Tibaldi, A Camerini, A D'Incecco, et al.
European Review for Medical and Pharmacological Sciences|November 24, 2006
Systemic lupus erythematosus and renal involvement: which role of citokines expression?A Gigante, D Amoroso, F Ferri, et al.
Chemotherapy|January 1, 1991
Oral chemotherapy with idarubicin plus cyclophosphamide in advanced breast cancerP Pronzato, G Bertelli, D Amoroso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Cisplatin and recombinant alpha interferon in advanced breast cancerP Pronzato, G Bertelli, D Amoroso, et al.
European Review for Medical and Pharmacological Sciences|June 25, 2004
Safety of conventional drugs and biologic agents for Rheumatoid ArthritisA Amoroso, A Gigante, C Gianni, et al.
Cancer Treatment Reports|December 1, 1986
Idarubicin in advanced breast cancer: a phase II studyR Lionetto, P Pronzato, P F Conte, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with interleukin-2 and interferon-alphaL Canobbio, A Rubagotti, L Miglietta, et al.
Anticancer Research|July 1, 1989
Adjuvant systemic treatment of resectable breast cancer: eleven years results of a monoinstitutional chemo-hormone-immunotherapy trialR Rosso, F Boccardo, F Brema, et al.
American Journal of Clinical Oncology|October 1, 1987
A phase II study with danazol in metastatic breast cancerP Pronzato, D Amoroso, A Ardizzoni, et al.
Anticancer Research|January 1, 1989
Continuous venous infusion of vindesine in metastatic breast cancer: experience with a subcutaneously implanted system and portable pumpD Amoroso, G Bertelli, P Pronzato, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Journal of Cancer Research and Clinical Oncology|July 7, 2012
First-line chemotherapy with planned sequential administration of cisplatin/gemcitabine followed by docetaxel in elderly 'unfrail' patients with advanced non-small-cell lung cancer: a multicenter phase II studyC Tibaldi, A Camerini, A D'Incecco, et al.
European Review for Medical and Pharmacological Sciences|November 24, 2006
Systemic lupus erythematosus and renal involvement: which role of citokines expression?A Gigante, D Amoroso, F Ferri, et al.
Chemotherapy|January 1, 1991
Oral chemotherapy with idarubicin plus cyclophosphamide in advanced breast cancerP Pronzato, G Bertelli, D Amoroso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Cisplatin and recombinant alpha interferon in advanced breast cancerP Pronzato, G Bertelli, D Amoroso, et al.
European Review for Medical and Pharmacological Sciences|June 25, 2004
Safety of conventional drugs and biologic agents for Rheumatoid ArthritisA Amoroso, A Gigante, C Gianni, et al.
Cancer Treatment Reports|December 1, 1986
Idarubicin in advanced breast cancer: a phase II studyR Lionetto, P Pronzato, P F Conte, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with interleukin-2 and interferon-alphaL Canobbio, A Rubagotti, L Miglietta, et al.
Anticancer Research|July 1, 1989
Adjuvant systemic treatment of resectable breast cancer: eleven years results of a monoinstitutional chemo-hormone-immunotherapy trialR Rosso, F Boccardo, F Brema, et al.
American Journal of Clinical Oncology|October 1, 1987
A phase II study with danazol in metastatic breast cancerP Pronzato, D Amoroso, A Ardizzoni, et al.
Anticancer Research|January 1, 1989
Continuous venous infusion of vindesine in metastatic breast cancer: experience with a subcutaneously implanted system and portable pumpD Amoroso, G Bertelli, P Pronzato, et al.
Pageof 9